CVSA Q1 Deep Dive: Enrollment Growth and Program Expansion Drive Upbeat Outlook

Vocational education company Covista (NYSE:CVSA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.5% year on year to $487 million. The company’s full-year revenue guidance of $1.94 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $1.98 per share was 14.9% above analysts’ consensus estimates.

Is now the time to buy CVSA? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Covista delivered a positive first quarter, surpassing Wall Street’s expectations for both revenue and non-GAAP earnings. Management highlighted that robust enrollment growth across all segments, particularly at Chamberlain and Walden universities, was the primary driver of performance. CEO Stephen Beard cited a return to positive total enrollment at Chamberlain, noting, “The operating changes that we committed to are, in fact, working.” Operational improvements in marketing and application processes also contributed to these results, reinforcing the company’s ability to execute its strategy.

Looking ahead, management’s raised full-year guidance is supported by continued investments in campus expansion, new program development, and partnerships with employers. Beard emphasized that Chamberlain’s new fast-track degree options and six campuses under development are expected to accelerate growth. He added that the launch of AI credentials and the AI-powered classroom pilot, in partnership with Google Cloud, exemplifies Covista’s focus on workforce readiness. CFO Robert Phelan noted that higher capital expenditures will support these initiatives, while ongoing operational discipline is expected to sustain margin improvements.

Key Insights from Management’s Remarks

Covista’s management attributed the quarter’s outperformance to broad-based enrollment gains, operational enhancements, and strategic investments across its education portfolio.

• Chamberlain enrollment turnaround: Chamberlain University achieved a return to positive total enrollment growth, driven by localized marketing, streamlined application processes, and recruitment of new leadership. The pre-licensure nursing segment maintained its strong growth, while post-licensure programs, such as RN to BSN and MSN, experienced sequential improvement. Management indicated that these changes restored funnel conversion rates to historical levels and anticipate further momentum as the fall enrollment cycle approaches.

• Walden’s sustained momentum: Walden University reported record enrollment, with year-over-year growth in both health care and non-health care programs. New offerings in clinical psychology and behavioral analysis attracted over 1,400 students, and enhanced retention strategies continued to yield higher persistence rates. Walden’s ability to rapidly launch in-demand programs is seen as a competitive advantage, supporting its ongoing enrollment expansion.

• Medical and veterinary segment strength: The medical and veterinary segment delivered healthy top-line gains, supported by operational efficiency and faster application review through workflow automation. Management emphasized strong academic outcomes, with high residency attainment rates and competitive internship placements, which enhance Covista’s reputation and drive student demand.

• AI and digital platform initiatives: Covista continued its partnership with Google Cloud to develop an AI-powered classroom, aiming to provide personalized learning support. Over 4,000 learners have already enrolled in new AI credential programs, validating demand for digital and workforce-relevant skills. The company also established an advisory council of health care leaders to ensure clinical rigor in its AI curriculum.

• Capital allocation and leadership additions: Free cash flow growth and reduced leverage provided flexibility for campus expansion and technology investments. The company refinanced long-term debt at lower rates and repurchased $66 million in stock. Covista also appointed Amelia Manning as Chamberlain’s new President and expanded Michael Betz’s role to oversee marketing and innovation, strengthening execution capabilities.

Drivers of Future Performance

Management’s outlook is shaped by targeted investments in campus growth, technology-enabled learning, and deepening employer partnerships, all of which are expected to drive high-single digit revenue growth and margin expansion.

• Campus expansion and new programs: Covista is actively developing six new Chamberlain campuses, with the first launching in September, and has several additional program approvals in high-demand fields such as palliative care and special education. Management believes these initiatives will boost enrollment and support sustained top-line growth.

• AI integration and digital credentials: The rollout of AI-driven learning platforms and credential programs, in partnership with Google Cloud, is expected to differentiate Covista’s educational offering and meet rising demand for workforce-ready skills. Management anticipates increased adoption of these digital tools will improve student outcomes and further integrate Covista with employer partners.

• Balanced capital deployment: Ongoing investment in operational improvements and technology is being balanced with disciplined capital allocation. Management cited flexibility to fund growth through free cash flow and recent debt refinancing, but cautioned that higher capital expenditures in the near term are necessary to achieve long-term scale and efficiency gains.

Catalysts in Upcoming Quarters

In upcoming quarters, our team will watch closely for (1) continued enrollment momentum at Chamberlain and Walden, especially as new campuses come online; (2) adoption rates and student outcomes from AI-powered learning initiatives and credential programs; and (3) progress on employer partnerships that could enhance student placement and institutional relevance. Execution on campus buildouts and integration of new leadership will also be critical markers.

Covista currently trades at $130.15, up from $117.01 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging for this month – FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.